CareRx to Present at 2023 Bloom Burton Co. Healthcare Investor Conference on Tuesday, April 25 at 4 00 pm ET - Marketscreener.com
| CHHHF Stock | USD 1.40 0.00 0.00% |
Roughly 61% of CareRx's investor base is looking to short. The analysis of overall sentiment of trading CareRx pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with CareRx's historical and current headlines, can help investors time the market. In addition, many technical investors use CareRx stock news signals to limit their universe of possible portfolio assets.
CareRx pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of CareRx daily returns and investor perception about the current price of CareRx as well as its diversification or hedging effects on your existing portfolios.
CareRx |
CareRx to Present at 2023 Bloom Burton Co. Healthcare Investor Conference on Tuesday, April 25 at 4 00 pm ET Marketscreener.com
Read at news.google.com
 |
CareRx Fundamental Analysis
We analyze CareRx's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CareRx using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CareRx based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Employees
Number Of Employees Comparative Analysis
CareRx is currently under evaluation in number of employees category among its peers. Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
CareRx Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with CareRx pink sheet to make a market-neutral strategy. Peer analysis of CareRx could also be used in its relative valuation, which is a method of valuing CareRx by comparing valuation metrics with similar companies.
Peers
CareRx Related Equities
| RMYHY | Ramsay Health | 0.00 |
| ||
| MFCSF | Medical Facilities | 0.56 |
|
Complementary Tools for CareRx Pink Sheet analysis
When running CareRx's price analysis, check to measure CareRx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CareRx is operating at the current time. Most of CareRx's value examination focuses on studying past and present price action to predict the probability of CareRx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CareRx's price. Additionally, you may evaluate how the addition of CareRx to your portfolios can decrease your overall portfolio volatility.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |